How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index.

Thanou, Aikaterini; Chakravarty, Eliza; James, Judith A; Merrill, Joan T

Thanou, Aikaterini; Chakravarty, Eliza; James, Judith A; Merrill, Joan T.

Afiliação

Thanou A; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Department of Internal Medicine, Section of Rheumatology, University of Oklahoma Health Science Center and Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA. a
Chakravarty E; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Department of Internal Medicine, Section of Rheumatology, University of Oklahoma Health Science Center and Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
James JA; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Department of Internal Medicine, Section of Rheumatology, University of Oklahoma Health Science Center and Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA. A
Merrill JT; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Department of Internal Medicine, Section of Rheumatology, University of Oklahoma Health Science Center and Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

Rheumatology (Oxford) ; 53(12): 2175-81, 2014 Dec.

Article em En | MEDLINE | ID: mdl-24729400

Assuntos

Lúpus Eritematoso Sistêmico/diagnóstico; Índice de Gravidade de Doença; Anti-Inflamatórios não Esteroides/uso terapêutico; Relação Dose-Resposta a Droga; Glucocorticoides/administração & dosagem; Glucocorticoides/uso terapêutico; Humanos; Estudos Longitudinais; Lúpus Eritematoso Sistêmico/tratamento farmacológico; Oklahoma; Prednisona/administração & dosagem; Prednisona/uso terapêutico; Recidiva; Reprodutibilidade dos Testes

Palavras-chave

BILAG; SELENA-SLEDAI flare index; SLEDAI; medications; outcome measures; physician's global assessment; revised SELENA flare index; systemic lupus erythematosus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Lúpus Eritematoso Sistêmico Tipo de estudo: Evaluation_studies / Observational_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google